Literature DB >> 17390218

Interaction of carboxyl-terminal peptides of cytosolic-tail of apactin with PDZ domains of NHERF/EBP50 and PDZK-1/CAP70.

Chanderdeep Tandon1, Robert C De Lisle, Igor Boulatnikov, Pradeep Kumar Naik.   

Abstract

The C-terminal PDZ-binding motifs are required for polarized apical/basolateral localization of many membrane proteins. Ezrin-radixin-moesin (ERM) proteins regulate the organization and function of specific cortical structures in polarized epithelial cells by connecting filamentous (F)-actin to plasma membrane proteins through EBP50. Previous work showed that the membrane phosphoprotein apactin (an 80-kDa type I membrane protein derived from pro-Muclin) is associated with the acinar cell apical actin cytoskeleton and that this association is modulated by changes in the phosphorylation state of the apactin cytosolic tail. The carboxyl-terminal amino acids of apactin (-STKL-COOH) are predicted to form a type I PDZ-binding domain, similar to that of CFTR (-DTRL-COOH). Pairwise sequence comparison between NHERF/EBP50 and PDZK1/CAP70 PDZ domains reveals significant identity among the 83 amino-acid residues (12-92) of EBP50 and CAP70 (241-323), which are involved in the interaction with the carboxyl-terminal peptides (STKL-COOH and phosphomimetics) of apactin. Hence, the specificity and affinity of interactions are identical between them, which is corroborated with the two hybrid results. Substitution of all the four-carboxyl-terminal amino acids in the wild type to Ala reduces the interaction. Only the carbonyl oxygen and amide nitrogen of Ala are found to be involved in hydrogen bonding. Further, truncation of the wild carboxyl-terminal peptide to RGQPP-COOH, showed very low affinity of interaction with PDZ1 domain. Only the atom O(epsilon1) of Gln-2 hydrogen bonds with N(epsilon2) of His72 of PDZ domain. Ser-3 amino acid in wild type apactin protein (STKL-COOH) is not involved in hydrogen bonding with PDZ1 domain. However, substitution of Ser-3 to Asp-3 in PDTKL-COOH peptide increases the affinity of interaction of PDTKL-COOH with PDZ1 domain. Thus, carboxyl-terminal Asp(D) -3, Thr(T) -2, Lys(K) -1 and Leu(L) 0 are involved in numerous interactions with PDZ1 domains of NHERF/EBP50 and PDZK1/CAP70.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390218     DOI: 10.1007/s11010-007-9437-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  NHERF associations with sodium-hydrogen exchanger isoform 3 (NHE3) and ezrin are essential for cAMP-mediated phosphorylation and inhibition of NHE3.

Authors:  E J Weinman; D Steplock; M Donowitz; S Shenolikar
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

Review 2.  PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane.

Authors:  A S Fanning; J M Anderson
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Recognition of unique carboxyl-terminal motifs by distinct PDZ domains.

Authors:  Z Songyang; A S Fanning; C Fu; J Xu; S M Marfatia; A H Chishti; A Crompton; A C Chan; J M Anderson; L C Cantley
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

4.  Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains.

Authors:  O Kocher; N Comella; K Tognazzi; L F Brown
Journal:  Lab Invest       Date:  1998-01       Impact factor: 5.662

5.  A modified version of the Cornell et al. force field with improved sugar pucker phases and helical repeat.

Authors:  T E Cheatham; P Cieplak; P A Kollman
Journal:  J Biomol Struct Dyn       Date:  1999-02

6.  Crystal structure of the hCASK PDZ domain reveals the structural basis of class II PDZ domain target recognition.

Authors:  D L Daniels; A R Cohen; J M Anderson; A T Brünger
Journal:  Nat Struct Biol       Date:  1998-04

7.  NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins.

Authors:  A Murthy; C Gonzalez-Agosti; E Cordero; D Pinney; C Candia; F Solomon; J Gusella; V Ramesh
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

8.  PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator.

Authors:  Agnieszka Swiatecka-Urban; Marc Duhaime; Bonita Coutermarsh; Katherine H Karlson; James Collawn; Michal Milewski; Garry R Cutting; William B Guggino; George Langford; Bruce A Stanton
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

9.  Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  S Wang; R W Raab; P J Schatz; W B Guggino; M Li
Journal:  FEBS Lett       Date:  1998-05-01       Impact factor: 4.124

10.  Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction.

Authors:  V Raghuram; D O Mak; J K Foskett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

View more
  4 in total

1.  PDZK1 binding and serine phosphorylation regulate subcellular trafficking of organic anion transport protein 1a1.

Authors:  Jo H Choi; John W Murray; Allan W Wolkoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-23       Impact factor: 4.052

2.  Structural basis for NHERF1 PDZ domain binding.

Authors:  Tatyana Mamonova; Maria Kurnikova; Peter A Friedman
Journal:  Biochemistry       Date:  2012-03-27       Impact factor: 3.162

3.  The ΔF508-CFTR mutation inhibits wild-type CFTR processing and function when co-expressed in human airway epithelia and in mouse nasal mucosa.

Authors:  Torry A Tucker; James A Fortenberry; Akos Zsembery; Lisa M Schwiebert; Erik M Schwiebert
Journal:  BMC Physiol       Date:  2012-09-24

4.  The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.

Authors:  Guifang Du; Yanan Gu; Chengcheng Hao; Zhu Yuan; Junqi He; Wen G Jiang; Shan Cheng
Journal:  Oncotarget       Date:  2016-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.